NDC 50090-1382-00 - IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-1382
- Requested NDC
- 50090-1382-00
- Package NDCs from labels
- 50090-1382-0, 50090-1382-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE - A-S Medication Solutions | A-S Medication Solutions | 2024-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-1382-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-f8c6-0266-e053-dadaa90a7c1a | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL (RDP) |
| 50090-1382-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-f8c6-0266-e053-dadaa90a7c1a | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL (RDP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-1382-0 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 3 mL in 1 VIAL | SOLUTION | 3 | 18 | |
| 50090-1382-0 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 30 in 1 CARTON | SOLUTION | 30 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-1382 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [A-S MEDICATION SOLUTIONS] | 18 | Current NDC, Legacy NDC, 2 package rows | 20240612_e452afc2-dc33-4be7-949e-143b2e5f530c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-1382-0 | ML - Milliliter | 50090-1382 | 99af8832-e85f-4b08-a889-7cb38083d22c | 1 | 2021-09-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Redpharm Drug | 594bb030-e6e5-1da4-e063-6394a90aba55 | 2026-08-18 | Warnings, Adverse reactions | ANDA202496 1437702 J697UZ2A9J 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Armstrong Pharmaceuticals, Inc. | 17858afa-dcdf-4612-b475-3b6baadfb639 | 2026-08-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals, Inc. | 583c6408-45cc-9121-e063-6294a90afcc4 | 2026-08-04 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Cardinal Health 107, LLC | 6b730dd7-4d93-403a-bfd2-fa0efa298b75 | 2026-07-24 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Rising Pharma Holdings, Inc. | 3249aea8-a395-f09f-e063-6294a90a2d8b | 2026-07-16 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3236f82c-14e9-dfd4-e063-6294a90ac43d | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3246dfab-61d7-27ba-e063-6294a90ac180 | 2026-07-16 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 32377c09-da6d-331c-e063-6294a90a7a46 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc | 32474c0e-af35-69d1-e063-6394a90a53c6 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | Sportpharm LLC | 7e8fdd92-1e55-47e2-aa85-e48cfebbb8d7 | 2026-07-14 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol Sulfate | ALBUTEROL SULFATE | HAWAII REPACK, INC. | b18fad6e-f117-4840-83b7-8c261c646af1 | 2026-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | 4aec7f59-b429-4b0e-a779-8df1dd8f80d7 | 2026-06-23 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Cipla USA Inc. | 3c64255e-074c-41f8-a344-3686a0685020 | 2026-06-22 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | 0f9bf2c8-55c0-4b4d-97de-d6c7220c3862 | 2026-06-17 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Cardinal Health 107, LLC | 51350fab-a919-4d97-9d0c-d9dc7286244c | 2026-06-02 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Redpharm Drug | 52c63e41-dbbc-d9d7-e063-6294a90a30c9 | 2026-05-27 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | A-S Medication Solutions | 65504330-6c02-4e30-9f32-51393e06f20c | 2026-05-22 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Cipla USA Inc. | c4d6d76a-14b8-411a-8019-e2c923c2c532 | 2026-05-20 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | b0a5da99-6553-4088-ae27-7fa194438340 | 2026-05-20 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 66f32a06-c880-4b5b-837b-951e1e01e040 | 2026-05-13 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.